Clinical Indicators for Intervention in AAA Disease

From the creator

(September 4, 2008) Ronald L. Dalman, MD discussions the shortcomings of monitoring AAA progression through diameter growth rates, which makes treatment of AAA disease difficult. Dalman concludes that more effective imaging during the early stages of the disease will increase therapeutic options for AAA disease. 2008 Stanford AAA Summit http://vascular.stanford.edu/news/summit.html Stanford School of Medicine http://med.stanford.edu/ Stanford Channel on YouTube: http://www.youtube.com/stanford

Published 2009-01-26 · Watch on YouTube ↗
Availability and playback restrictions are controlled by the original channel.